tetano
Editor, Senior Moderator
Respirology
. 2022 Apr 19.
doi: 10.1111/resp.14262. Online ahead of print.
Home monitoring of lung function, symptoms and quality of life after admission with COVID-19 infection: The HOMECOMIN' study
Gizal Nakshbandi[SUP] 1 [/SUP], Catharina C Moor[SUP] 1 [/SUP], Esther J Nossent[SUP] 2 [/SUP], J J Miranda Geelhoed[SUP] 3 [/SUP], Sara J Baart[SUP] 1 [/SUP], Bart G Boerrigter[SUP] 2 [/SUP], Joachim G J V Aerts[SUP] 1 [/SUP], Suzan F M Nijman[SUP] 2 [/SUP], Helger Y Santema[SUP] 3 [/SUP], Merel E Hellemons[SUP] 1 [/SUP], Marlies S Wijsenbeek[SUP] 1 [/SUP]
Affiliations
Abstract
Background and objective: To develop targeted and efficient follow-up programmes for patients hospitalized with coronavirus disease 2019 (COVID-19), structured and detailed insights in recovery trajectory are required. We aimed to gain detailed insights in long-term recovery after COVID-19 infection, using an online home monitoring programme including home spirometry. Moreover, we evaluated patient experiences with the home monitoring programme.
Methods: In this prospective multicentre study, we included adults hospitalized due to COVID-19 with radiological abnormalities. For 6 months after discharge, patients collected weekly home spirometry and pulse oximetry measurements, and reported visual analogue scales on cough, dyspnoea and fatigue. Patients completed the fatigue assessment scale (FAS), global rating of change (GRC), EuroQol-5D-5L (EQ-5D-5L) and online tool for the assessment of burden of COVID-19 (ABCoV tool). Mixed models were used to analyse the results.
Results: A total of 133 patients were included in this study (70.1% male, mean age 60 years [SD 10.54]). Patients had a mean baseline forced vital capacity of 3.25 L (95% CI: 2.99-3.44 L), which increased linearly in 6 months with 19.1% (Δ0.62 L, p < 0.005). Patients reported substantial fatigue with no improvement over time. Nevertheless, health status improved significantly. After 6 months, patients scored their general well-being almost similar as before COVID-19. Overall, patients considered home spirometry useful and not burdensome.
Conclusion: Six months after hospital admission for COVID-19, patients' lung function and quality of life were still improving, although fatigue persisted. Home monitoring enables detailed follow-up for patients with COVID-19 at low burden for patients and for the healthcare system.
Keywords: COVID-19; chronic lung disease; coronavirus disease; eHealth; health-related quality of life; home spirometry; patient-reported outcome measures; telemedicine.
. 2022 Apr 19.
doi: 10.1111/resp.14262. Online ahead of print.
Home monitoring of lung function, symptoms and quality of life after admission with COVID-19 infection: The HOMECOMIN' study
Gizal Nakshbandi[SUP] 1 [/SUP], Catharina C Moor[SUP] 1 [/SUP], Esther J Nossent[SUP] 2 [/SUP], J J Miranda Geelhoed[SUP] 3 [/SUP], Sara J Baart[SUP] 1 [/SUP], Bart G Boerrigter[SUP] 2 [/SUP], Joachim G J V Aerts[SUP] 1 [/SUP], Suzan F M Nijman[SUP] 2 [/SUP], Helger Y Santema[SUP] 3 [/SUP], Merel E Hellemons[SUP] 1 [/SUP], Marlies S Wijsenbeek[SUP] 1 [/SUP]
Affiliations
- PMID: 35441433
- DOI: 10.1111/resp.14262
Abstract
Background and objective: To develop targeted and efficient follow-up programmes for patients hospitalized with coronavirus disease 2019 (COVID-19), structured and detailed insights in recovery trajectory are required. We aimed to gain detailed insights in long-term recovery after COVID-19 infection, using an online home monitoring programme including home spirometry. Moreover, we evaluated patient experiences with the home monitoring programme.
Methods: In this prospective multicentre study, we included adults hospitalized due to COVID-19 with radiological abnormalities. For 6 months after discharge, patients collected weekly home spirometry and pulse oximetry measurements, and reported visual analogue scales on cough, dyspnoea and fatigue. Patients completed the fatigue assessment scale (FAS), global rating of change (GRC), EuroQol-5D-5L (EQ-5D-5L) and online tool for the assessment of burden of COVID-19 (ABCoV tool). Mixed models were used to analyse the results.
Results: A total of 133 patients were included in this study (70.1% male, mean age 60 years [SD 10.54]). Patients had a mean baseline forced vital capacity of 3.25 L (95% CI: 2.99-3.44 L), which increased linearly in 6 months with 19.1% (Δ0.62 L, p < 0.005). Patients reported substantial fatigue with no improvement over time. Nevertheless, health status improved significantly. After 6 months, patients scored their general well-being almost similar as before COVID-19. Overall, patients considered home spirometry useful and not burdensome.
Conclusion: Six months after hospital admission for COVID-19, patients' lung function and quality of life were still improving, although fatigue persisted. Home monitoring enables detailed follow-up for patients with COVID-19 at low burden for patients and for the healthcare system.
Keywords: COVID-19; chronic lung disease; coronavirus disease; eHealth; health-related quality of life; home spirometry; patient-reported outcome measures; telemedicine.